Featured,Trends & Articles Washington City Approves Measure to Decriminalize Psychedelics Substances By Dennis Mutua January 03, 2022 The city of Port Townsend becomes the latest entry in the list of United States cities to decriminalize possession and use of natural psychedelics also known as entheogenic fungi and plants. The city approved this measure last wee...
Spotlight Stock,Trends & Articles MindMed Announces Transitions in its Managerial Positions By Dennis Mutua December 30, 2021 Psychedelic medicine biotechnology company developing psychedelic-inspired medicine and therapies to treat addiction and mental illness MindMed Inc. (NASDAQ: MNMD) (NEO: MMED) has announced some transitions among its managerial po...
Featured,Trends & Articles Colorado Activists Files Petition to Legalize Psychedelics Substances By Dennis Mutua December 29, 2021 A group of activists from Colorado have filed a petition seeking to have growth and possession psychedelics substances across the state legalized come next year. The activist group is also advocating for establishment of a system ...
Featured,Trends & Articles Washington City Votes in Favor of Decriminalizing Psychedelics By Dennis Mutua December 23, 2021 Earlier in the week, the city council of Port Townsend, Washington voted in favor of decriminalizing fungi and entheogenic plants across the city. This move makes the city to join an expanding list of cities and states across the ...
Psychedelic Stocks,Trends & Articles MindMed’s Clinical Study Using LSD to Treat Generalized Anxiety Disorder Put on Hold by FDA By Dennis Mutua December 22, 2021 The United States Food and Drug Administration (FDA) announced having put on hold an application by MindMed Inc. (NASDAQ: MNMD) to conduct a clinical study using psychedelic compound commonly referred to as LSD to treat patients s...
Psychedelic Stocks,Trends & Articles Psyched Wellness Hires Del Mahabadi as its Marketing Consultant Ahead of AME-1 Product Launch By Dennis Mutua December 15, 2021 Health supplement company focusing on protection, restoration and regaining of a healthier body and mind through production and distribution of artisanal medical mushrooms Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) announced...
Featured,Trends & Articles DEA Revises 2022 Production Quotas for Psychedelics Upwards By Dennis Mutua December 13, 2021 The Drug Enforcement Agency (DEA) has revised upwards its 2022 production quotas for illicit controlled substances including MDMA, DMT and psilocybin for research purposes. This was communicated through a notice recently published...
Spotlight Stock,Trends & Articles MindMed Holds Pre-Submission Meeting With FDA Concerning MindMed Session Monitoring System By Dennis Mutua December 10, 2021 Psychedelic biotechnology company developing and commercializing psychedelic-inspired medicine and therapies to treat addiction and mental illnesses MindMed Inc. (NASDAQ: MNMD) (NEO: MMED) held a meeting with the U.S Food and Drug...